About this episode

The episode discusses how AI is transforming drug discovery and the future of medicine with insights from Ben Taylor of Recursion UK.

In this episode, Ed is joined by Ben Taylor, Chief Financial Officer and President of Recursion UK, to discuss how AI is reshaping drug discovery, biotech, and the future of medicine. Ben explains how Recursion uses AI, lab automation, biological data, and machine learning to improve the way new medicines are discovered and developed. They explore why drug discovery has such a high failure rate, how AI can open up new areas of biology, and what this could mean for healthcare over the next decade.

Explore listener stats, chart rankings, contacts and more on the Opto Sessions – Invest in the Next Big Idea podcast page.